In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
Jonathan A. Africa(University of California San Diego), Girish Subbarao, Kimberlee Bernstein, April Carr, Oscar W. Cummings(Indiana University Hospital), Miriam B. Vos(Emory University), Patricia Belt(Johns Hopkins University), Saul J. Karpen(Karolinska University Hospital), Nicholas Raviele, Rohit Kohil(Cincinnati Children's Hospital Medical Center), Molly Bozic, Kim M. Cecil, Rory Mahabir, Ryan Himes(Baylor College of Medicine), Joel E. Lavine(Columbia University), Ali Mencin, Alexander J. Towbin(Cincinnati Children's Hospital Medical Center), Stavra A. Xanthakos(Cincinnati Children's Hospital Medical Center), Emily Ragozzino, Sarah E. Barlow(Cook Children's Health Care System), Jean P. Molleston(Riley Hospital for Children), Kimberly P. Newton(University of California San Diego), Adina Alazraki, Jessica Cruz Muños, Ann Klipsch, Rebecca Cleeton, Kristin Bramlage, Leanel Maldonado, Yunjun Luo(University of California San Diego), Daniel J. Podberesky, Cynthia Behling(Johns Hopkins University), Jay H. Lefkowitch(Columbia College), Elizabeth M. Brunt(Washington University in St. Louis), Rohit Kohli(Children's Hospital of Los Angeles), Rajesh Krisnamurthy, Jeffrey B. Schwimmer(University of California San Diego), Elena Reynoso, María Cordero, Nan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Albert Hernández, Stephanie H. Abrams, Kathleen D. Lake, Kumar Sandrasegaran, Jiayi Hou(University of Hong Kong), Alan Wells(University of California San Diego), Gerald Behr, Peter F. Whitington(Lurie Children's Hospital), Stephanie DeVore
Cited by 77
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k